Description

Pyrazolo[3,4-B]Azepine, 3-(1-Ethyl-4-Piperidinyl)-1,4,5,6,7,8-Hexahydro- (9Ci) is a complex, nitrogen-rich heterocyclic compound that serves as a sophisticated building block in advanced organic synthesis. Its fused polycyclic structure, featuring both pyrazole and azepine moieties, makes it a valuable intermediate for the development of novel pharmacologically active molecules. This high-purity intermediate is primarily targeted at research and development teams within the pharmaceutical and agrochemical industries, where it is used to create new chemical entities with potential therapeutic or biocidal properties.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly for central nervous system (CNS) targets, due to its complex, brain-penetrant scaffold.
• Medicinal Chemistry Research: Used as a core structure for constructing diverse chemical libraries in high-throughput screening and structure-activity relationship (SAR) studies.
• Agrochemical Development: Serves as a building block for creating new active ingredients with potential herbicidal, fungicidal, or insecticidal activity.
• Chemical Biology Probe Synthesis: Utilized to develop molecular probes for studying enzyme function and biological pathways in academic and industrial research settings.
• Custom Synthesis & Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for the production of bespoke compounds for client projects.

Basic Information

Item	Detail
Product Name	Pyrazolo[3,4-B]Azepine, 3-(1-Ethyl-4-Piperidinyl)-1,4,5,6,7,8-Hexahydro- (9Ci)
CAS No.	585520-35-0
Molecular Formula	C14H23N3
Molecular Weight	233.36 g/mol
Synonyms	3-(1-Ethylpiperidin-4-yl)-1,4,5,6,7,8-hexahydropyrazolo[3,4-b]azepine; 1,4,5,6,7,8-Hexahydro-3-(1-ethyl-4-piperidinyl)pyrazolo[3,4-b]azepine; Pyrazolo[3,4-b]azepine, 1,4,5,6,7,8-hexahydro-3-(1-ethyl-4-piperidinyl)-; SCHEMBL11850079; AKOS040759623; ZINC000257400511; 585520-35-0
EINECS	Contact for details

Quality Control

Our production of Pyrazolo[3,4-B]Azepine, 3-(1-Ethyl-4-Piperidinyl)-1,4,5,6,7,8-Hexahydro- (9Ci) adheres to stringent quality protocols suitable for advanced intermediate synthesis. Each batch undergoes comprehensive analytical characterization to ensure identity, purity, and consistency. Certificates of Analysis (COA) are provided, detailing results from HPLC, NMR, and mass spectrometry. We support cGMP compliance for pharmaceutical applications and can tailor quality documentation to meet specific project or regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). This compound may be hygroscopic (moisture-sensitive); therefore, the container should be kept tightly sealed under an inert atmosphere (e.g., nitrogen or argon) for long-term storage to prevent degradation. Keep away from strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms
Identification (NMR)	Conforms
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.